ESMO COLLOQUIUM Sessions

ESMO COLLOQUIUM - Hepatocellular carcinoma treatment: Now, next and beyond

This educational activity is provided by ESMO and supported by Eisai.
View the ESMO colloquium details

ESMO COLLOQUIUM - Systemic therapies in unresectable hepatocellular carcinoma (HCC): 1st and later lines

This educational activity is provided by ESMO and supported by IPSEN.
View the ESMO colloquium details

ESMO COLLOQUIUM - Immune check point inhibitors: Are we ready for combination?

This educational activity is provided by ESMO and supported by Celgene.
View the ESMO colloquium details

ESMO COLLOQUIUM - Acute Myeloid Leukemia – Focus on FLT3-ITD mutation

This educational activity is provided by ESMO and supported by Daiichi Sankyo.
View the ESMO colloquium details

ESMO COLLOQUIUM - Are biosimilars the key to access, in practice?

This educational activity is provided by ESMO and supported by Amgen, MSD, Pfizer and Sandoz.
View the ESMO colloquium details

*Resources are not available.

All ESMO 2018 Resources

Last update: 23 October 2018